Press releases
- Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
- Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
- Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
More ▼
Key statistics
As of last trade, Enanta Pharmaceuticals Inc (9EP:FRA) traded at 11.30, 50.67% above the 52 week low of 7.50 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.50 |
---|---|
High | 11.60 |
Low | 11.30 |
Bid | 11.40 |
Offer | 11.80 |
Previous close | 11.20 |
Average volume | 0.29 |
---|---|
Shares outstanding | 21.18m |
Free float | 19.89m |
P/E (TTM) | -- |
Market cap | 264.11m USD |
EPS (TTM) | -6.25 USD |
Data delayed at least 15 minutes, as of Jun 03 2024 18:55 BST.
More ▼